The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells

References

• Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
   PubMed Web of Science ®Google Scholar
• Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity. 2011;34:293–302.
   PubMed Web of Science ®Google Scholar
• Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016;7:112–125.
   PubMedGoogle Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317.
   PubMed Web of Science ®Google Scholar
• Head KA, Jurenka JS. Inflammatory bowel disease Part 1: ulcerative colitis–pathophysiology and conventional and alternative treatment options. Altern Med Rev. 2003;8:247–283.
   PubMedGoogle Scholar
• Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.
   PubMed Web of Science ®Google Scholar
• Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986.
   PubMed Web of Science ®Google Scholar
• Schübeler D. Function and information content of DNA methylation. Nature. 2015;517:321–326.
   PubMed Web of Science ®Google Scholar
• Whyte JM, Ellis JJ, Brown MA, et al. Best practices in DNA methylation: lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis. Arthritis Res Ther. 2019;21:133.
   PubMed Web of Science ®Google Scholar
• Howell KJ, Kraiczy J, Nayak KM, et al. DNA methylation and transcription patterns in intestinal epithelial cells from pediatric patients with inflammatory bowel diseases differentiate disease subtypes and associate with outcome. Gastroenterology. 2018;154:585–598.
   PubMed Web of Science ®Google Scholar
• Kang K, Bae J-H, Han K, et al. A genome-wide methylation approach identifies a new hypermethylated gene panel in ulcerative colitis. Int J Mol Sci. 2016;17. DOI:10.3390/ijms17081291.
   Web of Science ®Google Scholar
• Kraiczy J, Nayak K, Ross A, et al. Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease. Mucosal Immunol. 2016;9:647–658.
   PubMed Web of Science ®Google Scholar
• Birney E, Smith GD, Greally JM. Epigenome-wide association studies and the interpretation of disease -omics. PLoS Genet. 2016;12:e1006105.
   PubMed Web of Science ®Google Scholar
• Pacis A, Mailhot-Léonard F, Tailleux L, et al. Gene activation precedes DNA demethylation in response to infection in human dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 2019;116:6938–6943.
   PubMed Web of Science ®Google Scholar
• Zilberman D, Gehring M, Tran RK, et al. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet. 2007;39:61–69.
   PubMed Web of Science ®Google Scholar
• Ball MP, Li JB, Gao Y, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 2009;27:361–368.
   PubMed Web of Science ®Google Scholar
• Foran E, Garrity-Park MM, Mureau C, et al. Upregulation of DNA methyltransferase–mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res. 2010;8:471–481.
   PubMed Web of Science ®Google Scholar
• Martin M, Ancey P-B, Cros M-P, et al. Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch. BMC Genomics. 2014;15:435.
   PubMed Web of Science ®Google Scholar
• Wehbe H, Henson R, Meng F, et al. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res. 2006;66:10517–10524.
   PubMed Web of Science ®Google Scholar
• Soubières AA, Poullis A. Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther. 2016;7:41–50.
   PubMedGoogle Scholar
• Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014;15:R31.
   PubMed Web of Science ®Google Scholar
• Baron U, Turbachova I, Hellwag A, et al. DNA methylation analysis as a tool for cell typing. Epigenetics. 2006;1:55–60.
   PubMed Web of Science ®Google Scholar
• Barnicle A, Seoighe C, Greally JM, et al. Inflammation-associated DNA methylation patterns in epithelium of ulcerative colitis. Epigenetics. 2017;12:591–606.
   PubMed Web of Science ®Google Scholar
• Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis. 2012;33:723–731.
   PubMed Web of Science ®Google Scholar
• Hahn MA, Hahn T, Lee D-H, et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 2008;68:10280–10289.
   PubMed Web of Science ®Google Scholar
• Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61:3573–3577.
   PubMed Web of Science ®Google Scholar
• Laird PW. Early detection: the power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3:253–266.
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Gao Y, Jones A, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478.
   PubMed Web of Science ®Google Scholar
• Huang H, Fang M, Jostins L, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547:173–178.
   PubMed Web of Science ®Google Scholar
• de Lange KM, Moutsianas L, Lee JC, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet. 2017;49(2):256–261. doi:10.1038/ng.3760.
   Google Scholar
• Ventham NT, Kennedy NA, Adams AT, et al. Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease. Nat Commun. 2016;7:13507.
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.
   PubMed Web of Science ®Google Scholar
• McRae AF, Marioni RE, Shah S, et al. Identification of 55,000 replicated DNA methylation QTL. Sci Rep. 2018;8:17605.
   PubMed Web of Science ®Google Scholar
• Fernandez-Jimenez N, Garcia-Etxebarria K, Plaza-Izurieta L, et al. The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Sci Rep. 2019;9:1298.
   PubMed Web of Science ®Google Scholar
• McDermott E, Ryan EJ, Tosetto M, et al. DNA methylation profiling in inflammatory bowel disease provides new insights into disease pathogenesis. J Crohns Colitis. 2016;10:77–86.
   PubMed Web of Science ®Google Scholar
• Somineni HK, Venkateswaran S, Kilaru V, et al. Blood-derived DNA methylation signatures of crohn’s disease and severity of intestinal inflammation. Gastroenterology. 2019;156:2254–2265.e3.
   PubMed Web of Science ®Google Scholar
• Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis. 2015;21:453–467.
   PubMed Web of Science ®Google Scholar
• Hansen KD, Timp W, Bravo HC, et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 2011;43:768–775.
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Jones A, Fiegl H, et al. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med. 2012;4:24.
   PubMed Web of Science ®Google Scholar
• Fernandez AF, Assenov Y, Martin-Subero JI, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22:407–419.
   PubMed Web of Science ®Google Scholar
• Kettunen E, Hernandez-Vargas H, Cros M-P, et al. Asbestos-associated genome-wide DNA methylation changes in lung cancer: DNA methylation profiles in lung cancer. Int J Cancer. 2017;141:2014–2029.
   PubMed Web of Science ®Google Scholar
• Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.
   PubMed Web of Science ®Google Scholar
• Hannon E, Gorrie-Stone TJ, Smart MC, et al. Leveraging DNA-methylation quantitative-trait loci to characterize the relationship between methylomic variation, gene expression, and complex traits. Am. J. Hum. Genet. 2018;103:654–665.
   PubMed Web of Science ®Google Scholar
• Richardson TG, Haycock PC, Zheng J, et al. Systematic Mendelian randomization framework elucidates hundreds of CpG sites which may mediate the influence of genetic variants on disease. Hum. Mol. Genet. 2018;27:3293–3304.
   PubMed Web of Science ®Google Scholar
• Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 2015;47:172–179.
   PubMed Web of Science ®Google Scholar
• Yamamoto-Furusho JK, Ascaño-Gutiérrez I, Furuzawa-Carballeda J, et al. Differential Expression of MUC12, MUC16, and MUC20 in patients with active and remission ulcerative colitis. Mediators Inflamm. 2015;2015:659018.
   PubMed Web of Science ®Google Scholar
• Tao G-Z, Strnad P, Zhou Q, et al. Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2007;5:857–864.
   PubMed Web of Science ®Google Scholar
• Vuitton L, Koch S, Peyrin-Biroulet L. Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment. Curr Drug Targets. 2013;14:1385–1391.
   PubMed Web of Science ®Google Scholar
• Lundin KE, Gjertsen HA, Scott H, et al. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994;41:24–27.
   PubMed Web of Science ®Google Scholar
• Chiba H, Kakuta Y, Kinouchi Y, et al. Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease. PLoS ONE. 2018;13:e0194036.
   PubMed Web of Science ®Google Scholar
• Muro M, López-Hernández R, Mrowiec A. Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region. World J Gastroenterol. 2014;20:15037–15048.
   PubMed Web of Science ®Google Scholar
• Sandoval J, Heyn H, Moran S, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011;6:692–702.
   PubMed Web of Science ®Google Scholar
• Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
   PubMed Web of Science ®Google Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363–1369.
   PubMed Web of Science ®Google Scholar
• Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17. DOI:10.1186/s13059-016-1066-1.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203–209.
   PubMed Web of Science ®Google Scholar
• Xu Z, Niu L, Li L, et al. ENmix: a novel background correction method for illumina humanmethylation450 BeadChip. Nucleic Acids Res. 2016;44:e20–e20.
   PubMed Web of Science ®Google Scholar
• Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14:R115.
   PubMed Web of Science ®Google Scholar
• Pidsley R, Y Wong CC, Volta M, et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013;14:293.
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882–883.
   PubMed Web of Science ®Google Scholar
• Titus AJ, Gallimore RM, Salas LA, et al. Cell-type deconvolution from DNA methylation: a review of recent applications. Hum Mol Genet. 2017;26:R216–R224.
   PubMed Web of Science ®Google Scholar
• Smyth GK, Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 3: Article3. 2004; 10.2202/1544-6115.1027.
   PubMedGoogle Scholar
• Peters TJ, Buckley MJ, Statham AL, et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015;8:6.
   PubMed Web of Science ®Google Scholar
• Teschendorff AE, Gao Y, Jones A, et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat Commun. 2016;7:10478.
   PubMed Web of Science ®Google Scholar
• Slieker RC, Bos SD, Goeman JJ, et al. Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array. Epigenetics Chromatin. 2013;6:26.
   PubMed Web of Science ®Google Scholar